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ABSTRACT 
Objective: An accurate, simple, reproducible and sensitive method for the determination of paracetamol in pharmaceutical dosage form was 
developed and validated using a reversed-phase C18 
Methods: A mixture of Acetonitrile: 10 mM potassium dihydrogen orthophosphate buffer (15:85 v/v), pH 2.5 was used as a mobile phase at the 
flow rate of 1.0 ml/min and detector wavelength at 210 nm. The retention time of paracetamol was found to be 5.7 minutes (min). The method was 
statistically validated for the linearity, accuracy, precision and robustness.  
column (250 mm X 4.6 mm i. d, 5 µm particle size) with isocratic elution.  
Results: The linearity of paracetamol was in the range of 25.00 to 60.00µg/ml. This method showed an excellent linear response with the 
correlation coefficient (R2
Conclusion: The proposed method was cost effective, which can be used for the estimation of paracetamol in bulk and in solid dosage forms.  
) value of 0.999 for the paracetamol. The recovery of the drug was ranged from 99.51 to 100.68%. An intra-day and inter-
day precision study of the new method was less than the maximum allowable limit (% RSD<2.0).  
Keywords: Paracetamol, RP-HPLC, Isocratic, Retention time, Validation. 
 
INTRODUCTION 
Paracetamol (PCM) is one of the most accepted analgesic and 
antipyretic drug and is used in the treatment of pain and fever in 
adults and children. PCM exists in varied dosage forms like tablets, 
capsules, suspensions and suppositories [1, 2]. PCM is the de-
ethylated active metabolite of phenacetin, with molecular formula of 
C8H9NO2 and molecular weight of 151.16. Its chemical structure is 
given in fig. 1. 
 
Fig. 1: Chemical structure of paracetamol 
 
PCM has analgesic, antipyretic and weak anti-inflammatory 
activity. The exact mechanism by which, paracetamol produces its 
analgesic and antipyretic effects remains undefined. The primary 
mechanism of action is believed to be inhibition of cyclooxygenase 
(COX), with a predominant effect on COX-2. Inhibition of COX 
enzymes prevents the metabolism of arachidonic acid to 
prostaglandin H 2, an unstable intermediate byproduct which is 
converted to pro-inflammatory compounds. In the central nervous 
system, inhibition of COX enzymes reduces concentrations of 
prostaglandin E2
Development of analytical method for the assessment of drugs in 
pharmaceutical dosage form is of utmost necessity to confirm the 
quality of tablets with respect to assay. Various methods such as 
spectrophotometry and High Performance Liquid Chromatography 
(HPLC) methods have been reported for the analysis of paracetamol 
alone or in combination with other drugs in pharmaceutical 
preparations. But the reported methods were less sensitive with 
unsatisfied peak shape and less theoretical plates [6, 7]. The purpose 
of the current effort is to develop and validate a new analytical 
method for the determination of PCM in tablet dosage form. In this 
proposed method, we have put an effort to develop a cost-effective, 
rapid, and robust Reverse Phase High Performance Liquid 
Chromatography (RP-HPLC) method with enough data of validation 
parameters. However, to the best of our knowledge, using isocratic 
RP-HPLC method, we have used less organic phase for the 
estimation of PCM as compared to the reported studies [2, 8-11].  
, which lowers the hypothalamic set-point to 
reduce fever, and activation of descending inhibitory serotonergic 
pathways to produce analgesia [3-5]. 
MATERIALS AND METHODS 
All the chemicals and reagents were used in this method were 
analytical reagent grade and were obtained from Merck India. HPLC 
grade acetonitrile and potassium dihydrogen orthophosphate were 
obtained from S. D. Fine Chem Ltd. Deionized 18.2 MΩ water was used 
during the analysis was obtained by the water purification system 
(ELGA, UK). PCM Tablets IP 500 mg (Calpol Tablets) was obtained 
from our medical college Pharmacy. The HPLC-2010CHT 
Chromatographic conditions 
(Shimadzu, 
Japan) was equipped with UV detector, quaternary gradient pump and 
auto injector with 100 µl fixed loop and the analyte was monitored at 
210 nm. Chromatographic analysis was performed on a phenomenex 
C18 column having 250 cmX4.6 mm i. d and 5 µm particle size. All the 
drugs and the chemicals were weighed on the electronic balance 
(BSA224S-CW, Sartorius, Germany). The mobile phase was filtered 
through 0.2µ membrane filter and degassed. The determination of 
PCM was performed at ambient temperature. 
The phenomenex C-18 column was equilibrated with the mobile 
phase, acetonitrile: 10 mM potassium dihydrogen phosphate15:85 
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(v/v); pH 2.5. The active drug was monitored with UV detector at 
210 nm, and the injection volume was 50 µl. The flow rate was 
maintained at 1.0 ml/min and the total run time was kept 8 min. 
Preparation of standard stock solution 
10.00 milligram (mg) of PCM was weighed and transferred to 10 mL 
volumetric flask and dissolved in the mobile phase (diluent) to get a 
solution containing 1 mg/ml.  
Preparation of working standard solution 
The stock solution was diluted with mobile phase to obtain the 
working standard of 50µg/ml. 
Preparation of sample solution 
Twenty tablets, each containing 500 mg of PCM weighed and finely 
powdered; a quantity of powder equivalent to 50 mg of PCM was 
weighed and transferred to 100 mL volumetric flask. To this 20 mL 
of diluent was added and kept for the sonication for 30 min, later 
made up to the volume by using diluent. The sample solution was 
filtered through 0.20 µm membrane filter, and then 5 ml of filtrate 
was further diluted to 50 mL volumetric flask by using diluent to get 
a concentration of 50µg/ml.  
Method validation 
All the method validation parameters such as accuracy, linearity, 
precision, detection limit, quantification limit and robustness were 
validated as per the International Conference on Harmonization 
(ICH) guidelines [12]. 
System suitability parameters 
To evaluate system suitability parameters such as theoretical plates, 
tailing factor and retention time of six replicate injections of 
standard paracetamol of concentration 50µg/ml was used and the % 
RSD values were calculated. 
Linearity and range 
The linearity was analyzed through the standard curves ranging 
from 25.0µg/ml to 60.0µg/ml. The linearity was evaluated by linear 
regression analysis, which was calculated by the least-square 
regression analysis. 
Accuracy 
The truthfulness of an analytical method expresses the closeness 
between the expected value and the value found. In the present 
study, consecutive analysis (n=3) for three different concentration of 
the standard mixture (80, 100 and 120% of the nominal 
concentration) was carried out to verify the accuracy of the 
proposed method. 
Precision 
Precision of the method was determined by repeatability (intra-day 
precision) and intermediate precision (inter-day precision) of both 
standard and sample solutions. Precision was determined in six 
replicates of both standard and sample solutions. The results were 
expressed as % RSD of the measurements. 
Sensitivity 
Limit of Detection (LOD) and Limit of Quantification (LOQ) was 
determined using calibration curve method according to ICH Q2 
(R1) recommendations [12]. The LOD (k = 3.3) and LOQ (k = 10) 
of the proposed method was calculated using the following 
equation:  
A = kσ/S, where A = LOD or LOQ, σ is the standard deviation of the 
response, and S is the slope of the calibration curve. 
Robustness 
To determine the robustness of the current method, the effect of 
flow rate was studied at 0.9 mL and 1.1 mL/min instead of 1.0 
mL/min. The effect of pH was studied at 2.4 and 2.6 instead of 2.5. 
The effect of mobile phase composition was assessed at (Buffer: ACN 
= 86.5:13.5, v/v) and (Buffer: ACN = 83.5:16.5, v/v) instead of 
(Buffer: ACN = 85:15 v/v). The % RSD of robustness testing under 
these conditions was calculated. 
RESULTS AND DISCUSSION  
The main objective of the chromatographic method was to 
develop a precise, specific RP-HPLC method for the estimation of 
PCM. In order to develop a suitable isocratic RP-HPLC method, 
different buffer pH, organic solvent concentration and column 
chemistry were applied to achieve the isocratic elution of 
paracetamol. The mobile phase acetonitrile: 10 mM potassium 
dihydrogen orthophosphate (15:85 v/v) adjusted pH 2.5 using 
orthophosphoric acid with the flow rate of 1.0 mL/min and 
detector wavelength at 210 nm was found to be satisfactory.  
The retention time of PCM was 5.6 min. Our proposed method 
has good symmetrical peak shape, theoretical plates and tailing 
factor as compared to reported studies [6, 7]. The mobile phase 
used in the present method has less organic phase as compared 
to other studies [2, 6-9, 13]. This may decrease cost of analysis, 
which may be economical to quality control labs. The typical 
chromatogram of the assay solution is shown in fig. 2. 
System suitability 
The results (mean±%RSD of six replicates) of the chromatographic 
parameters are shown in table 1, indicating the good performance of 
the system.  
Linearity and range 
The linearity of the method was determined at seven concentration 
levels ranging from 25.0µg/ml to 60.0µg/ml for PCM.  
The calibration curve was constructed by plotting response 
factor against the concentration of drugs. The slope and the 
intercept value for the calibration curve was, y = 15839x+15476 
(r2
 
= 0.999) for the PCM. The result show that an excellent 
correlation exists between the response factor and the 
concentration of drug. The linearity range was comparatively 
better than the reported studies [7, 11], which may help in 
detecting lower concentration of the drug. The calibration curve 
is shown in fig. 3. 
 
Fig. 2: Typical chromatogram of assay solution 
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Table 1: Results of system suitability parameters 
 S. No.   Parameter   Value (mean±% RSD)* 
1  Retention Time   5.363±0.009 
2  Peak Area   7809879±0.119 
3  Theoretical plates   8976±0.897 
4   Tailing factor    1.02±0.173 
 * Mean and % relative standard deviation of six replicates.  
 
 
Fig. 3: Calibration curve for Paracetamol 
 
Accuracy 
Accuracy of the developed method was determined by the method of 
standard addition. Known amount of PCM solution was added to a 
pre quantified sample solution, and the amount of PCM was 
estimated by measuring the peak areas. The percentage recovery 
varied from 99.90 to 100.58 for PCM, indicating good accuracy of the 
method. Percentage recovery of PCM drug was calculated and shown 
below in the table 2.  
Precision 
The precision of the method was determined by intra-day precision 
and inter-day precision of both standard and sample solutions. 
Precision was determined in six replicates of both standard 
(50µg/ml) and sample solutions (50µg/ml). The results were 
expressed as %RSD of the measurements. % RSD values were below 
2% signifies a good precision. The repeatability, intra-day and inter-
day results are shown in the table 3(A-D). 
Sensitivity 
The LOD and LOQ were established by evaluating the minimum level 
at which the analyte could be readily detected and quantified with 
accuracy, respectively. The LOD and LOQ of PCM by the proposed 
method were found to be 0.02µg/ml and 0.06µg/ml, respectively as 
shown in table 4. 
 
Table 2: Results of recovery studies 
Concentration of Added amount  Amount recovered  Amount recovered   RSD  
Paracetamol (%)  
(n=3) 
 (mg) (mg) (%)(mean±SD)* (%)  
80 3.512 3.508  99.90±0.357  0.36 
100 4.390 4.409  100.43±0.145 0.14 
120 5.268 5.299  100.58±0.119 0.12 
* mean±Standard Deviation of three replicates.  
 
Table 3: Results of method precision 
A. Repeatability 
S. No.   Sample Area  Amount Recovered (in mg)  % Recovery 
1 7759330 497.96 99.59 
2 7773639 499.42 99.88 
3 7770331 498.51 99.70 
4 7765042 498.71 99.74 
5 7774421 499.08 99.82 
6 7776524 498.75 99.75 
 Mean  7769881 498.74 99.75 
Std Dev 5969.4 0.4981  0.0999 
% RSD  0.08  0.10  0.10 
 
B. Intermediate precision (Day 1) 
S. No.   Sample Area  Amount Recovered (in mg)  % Recovery 
1 7762565 498.78 99.76 
2 7783404 500.35  100.07 
3 7781845 499.86 99.97 
4 7761433 499.41 99.88 
5 7786419 500.08  100.02 
6 7784785 500.28  100.06 
 Mean  7776742 499.79 99.96 
Std Dev 10520.7 0.6012  0.1202 
% RSD   0.14  0.12  0.12 
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C. Intermediate precision (Day 2) 
S. No.  Sample Area Amount Recovered (in mg)  % Recovery 
1 7752615 499.41 99.88 
2 7774855 500.76 100.15 
3 7768489 500.98 100.2 
4 7751219 499.63 99.93 
5 7772985 501.58 100.32 
6 7777442 501.16 100.23 
 Mean  7766268 500.59 100.12 
Std Dev 10500.2 0.8718 0.175 
% RSD  0.14 0.17 0.17 
 
D. Comparison between Intermediate Precision Day 1 (Analyst 1) and Intermediate Precision Day 2 (Analyst 2) 
Sample 
 
Taken amount of sample 
Paracetamol (mg) 
Analyst-1 Analyst-2  
Amount found(mg) % Recovery±SD* Amount found(mg) % Recovery± SD* 
 Calpol  
500 mg Tablet  
500 499.79  99.96±0.120  500.59  100.12±0.175  
* % of Recovery±Standard Deviation of six samples (assay). 
 
Table 4: Results of LOD and LOQ 
 S. No.  Parameters  Paracetamol 
 1  LOD 0.02 (µg/ml) 
 2  LOQ  0.06 (µg/ml) 
 
Table 5: Robustness of the method 
Parameter  Amount of paracetamol Amount of paracetamol % RSD 
added (µg/ml) detected (mean±SD)* 
 Buffer: ACN = 86.5:13.5  50 49.80±0.19 0.13 
Change in mobile phase composition  Buffer: ACN = 85:15  50 50.30±0.28 0.08 
 Buffer: ACN = 83.5:16.5  50 50.60±0.14 0.37 
Change in pH mobile phase  2.40  50 50.90±0.53 0.05 
 2.50  50 50.30±0.28 0.08 
 2.60  50 51.30±0.64 0.01 
Change in flow rate 0.9 mL/min  50 50.50±0.32 0.34 
 1.0 mL/min  50 50.30±0.28 0.08 
  1.1 mL/min  50 51.20±0.64 0.37 
* mean±Standard Deviation of six replicates. 
 
Robustness 
The %RSD of robustness testing under different altered conditions is 
indicating that the current method is robust. Slight deliberate 
changes were made from the optimized parameters to check the 
robustness of the method. The method was found to be rugged and 
the results are shown in the table 5 
CONCLUSION 
The proposed study describes HPLC method for the identification 
and quantification of PCM. The method was validated and found to 
be simple, sensitive, rapid, accurate and precise. The developed 
method was cost effective as compared to the reported methods. 
The high percentage of recovery shows that the method can be 
successfully used for routine analysis. Hence the present RP-HPLC 
method is suitable for the quality control analysis of raw materials, 
formulation and stability studies. 
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